Elevance Health Inc.
New York Stock ExchangeTotal Valuation
Elevance Health Inc. carries a market capitalization of 85.80B, placing it among publicly traded companies globally. Its enterprise value stands at 61.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 85.80B |
| Enterprise Value | 61.19B |
Share Statistics
Elevance Health Inc. currently has 217.37M shares outstanding.
| Shares Outstanding | 217.37M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Elevance Health Inc. trades at a trailing price-to-earnings ratio of 12.35. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 1.81.
| PE Ratio | 12.35 |
| PS Ratio | 0.32 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 14.05 |
| P/FCF Ratio | 7.45 |
| P/OCF Ratio | 8.52 |
Enterprise Valuation
| EV / Sales | 0.31 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 6.15 |
Financial Position
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 72.30 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 14.91 |
| Return on Assets (ROA) | 4.27 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 9.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Elevance Health Inc. has paid 980.00M in income taxes, reflecting an effective tax rate of 15.76.
| Income Tax | 980.00M |
| Effective Tax Rate | 15.76 |
Stock Price Statistics
Elevance Health Inc.'s stock has gained approximately 6.0899% over the past 52 weeks. The 50-day moving average sits at 376.16, while the 200-day moving average is 341.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6.0899% |
| 50-Day Moving Average | 376.16 |
| 200-Day Moving Average | 341.56 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Elevance Health Inc. generated 200.42B in revenue and converted that into 5.24B in net income, yielding earnings per share of 23.49.
| Revenue | 200.42B |
| Gross Profit | N/A |
| Operating Income | N/A |
| Pretax Income | 6.22B |
| Net Income | 5.24B |
| EBITDA | N/A |
| EBIT | N/A |
| Earnings Per Share (EPS) | 23.49 |
Balance Sheet
Elevance Health Inc. holds 35.56B in cash and equivalents against 31.84B in total debt, resulting in a net debt position of 22.19B.
| Cash & Cash Equivalents | 35.56B |
| Total Debt | 31.84B |
| Net Debt | 22.19B |
| Equity (Book Value) | 35.80B |
| Book Value Per Share | 161.81 |
| Working Capital | N/A |
Cash Flow
Elevance Health Inc. produced 7.61B in operating cash flow over the past twelve months. After subtracting -1.15B in capital expenditures, free cash flow totaled 6.45B - equivalent to 29.15 per share.
| Operating Cash Flow | 7.61B |
| Capital Expenditures | -1.15B |
| Free Cash Flow | 6.45B |
| FCF Per Share | 29.15 |
Margins
Elevance Health Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics.
| Gross Margin | 100.00 |
| Operating Margin | N/A |
| Pretax Margin | 3.10 |
| Profit Margin | 2.62 |
| EBITDA Margin | N/A |
Dividends & Yields
The company's payout ratio of 29.04 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 6.87 |
| Dividend Yield | N/A |
| Payout Ratio | 29.04 |
| Shareholder Yield | 3.62 |
| FCF Yield | 13.42 |
Stock Splits
Elevance Health Inc.'s most recent stock split took place on June 1, 2005 with a 1:2 split ratio.
| Last Split Date | 6/1/2005 |
| Split Ratio | 1:2 |
Scores
Elevance Health Inc. posts an Altman Z-Score of 3.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.38 |